Form 8-K - Current report:
SEC Accession No. 0001171843-25-006690
Filing Date
2025-10-28
Accepted
2025-10-28 07:45:26
Documents
12
Period of Report
2025-10-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_102825.htm   iXBRL 8-K 29999
  Complete submission text file 0001171843-25-006690.txt   194710

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE edsa-20251028.xsd EX-101.SCH 3029
3 XBRL LABEL FILE edsa-20251028_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE edsa-20251028_pre.xml EX-101.PRE 22368
15 EXTRACTED XBRL INSTANCE DOCUMENT f8k_102825_htm.xml XML 3503
Mailing Address 100 SPY COURT MARKHAM Ontario, Canada
Business Address 100 SPY COURT MARKHAM Ontario, Canada (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 251421457
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)